Myriad Uranium Corp

As of April 30, 2026, Myriad Uranium Corp carries a market capitalization of 54.99M, placing it among publicly traded companies globally. Its enterprise value stands at 46.19M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Myriad Uranium Corp's next confirmed earnings release is scheduled for December 23, 2026.

As of April 30, 2026, Myriad Uranium Corp has 109.99M shares outstanding.

These figures are as of April 30, 2026.

As of April 30, 2026, Myriad Uranium Corp maintains a current ratio of 27.62, meaning it holds 27.6x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended April 30, 2026, Myriad Uranium Corp posted a negative return on equity (ROE) of -79.73, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -75.87, reflecting losses generated across the asset base.

As of the close on October 22, 2026, Myriad Uranium Corp's stock has declined approximately 27.96% over the past 52 weeks. The 50-day moving average sits at 0.43, while the 200-day moving average is 0.47.

Over the twelve months ended April 30, 2026, Myriad Uranium Corp generated - - in revenue and converted that into -6.30M in net income, yielding earnings per share of -0.07. EBITDA reached -6.41M, while operating income came in at -6.41M.

These figures are as of April 30, 2026. Total book value stands at 11.79M, with working capital of 9.74M providing operational flexibility.

Myriad Uranium Corp produced -4.88M in operating cash flow over the twelve months ended April 30, 2026. After subtracting -959,478.00 in capital expenditures, free cash flow totaled -5.84M - equivalent to -0.07 per share.

These figures cover the twelve months ended April 30, 2026. Free cash flow yield is negative at -13.05: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -19.48, meaning Myriad Uranium Corp raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of April 30, 2026, Myriad Uranium Corp has an Altman Z-Score of 87.07, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.